Invacare Compliance Challenges, Product Delays Impact Q3 Results

Talks with FDA are ongoing about compliance with quality system regulations and a proposed consent decree that would shut down certain operations at a wheelchair manufacturing plant in Elyria, Ohio, executives said during the firm’s Oct. 25 earnings call.

More from Regulation

More from Policy & Regulation